Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Market Cap	1.80B
Revenue (ttm)	226.30M
Net Income (ttm)	9.95M
Shares Out	2.40M
EPS (ttm)	4.15
PE Ratio	181.29
Forward PE	n/a
Dividend	1.00 (0.13%)
Ex-Dividend Date	Dec 3, 2024

Volume	3,855
Average Volume	6,545
Open	743.30
Previous Close	769.60
Day's Range	743.10 - 774.00
52-Week Range	652.00 - 1,002.70
Beta	-0.34
RSI	47.26
Earnings Date	Apr 16, 2025

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal, anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid dr...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 529
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AMBEEPHA

Financial Performance

In 2024, Ambee Pharmaceuticals's revenue was 219.30 million, an increase of 10.71% compared to the previous year's 198.10 million. Earnings were 9.68 million, an increase of 6.53%.